Read + Share
Freeman SD, Thomas A, Thomas I, Hills RK, et al. Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in
older patients with AML: the UK NCRI AML18 trial. Blood 2023;142:1697-1707.
PMID: 37595359
|
 |
|
Freeman SD, Thomas A, Thomas I, Hills RK, et al. Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in
older patients with AML: the UK NCRI AML18 trial. Blood 2023;142:1697-1707.
PMID: 37595359
|
|
|
|